Research Article
Serum Creatinine Level: A Supplemental Index to Distinguish Duchenne Muscular Dystrophy from Becker Muscular Dystrophy
Table 1
The number (percentage) of patients available for clinical analysis.
| | Clinical analysis | Number | Percentage (%) |
| | Clinical phenotype | 212 | | | DMD | 148 | 69.81% | | BMD | 52 | 24.53% | | IMD | 12 | 5.66% | | Blood test | 190 | | | Testing for Crn level | 190 | 100% | | Testing for cystatin C level | 190 | 100% | | Vignos scale | 187 | | | Degree (1–6) | 173 | 92.51% | | Degree (7–9) | 14 | 7.49% | | Mutation analysis | 195 | | | Large rearrangements | 136 | 69.74% | | Smaller mutations | 42 | 21.54% | | No large rearrangements | 17 | 8.72% |
|
|
DMD: Duchenne muscular dystrophy; BMD: Becker muscular dystrophy; IMD: intermediate muscular dystrophy; Crn: creatinine.
|
